
We conducted an zzso dose zzso study to assess the efficacy and zzso of zzso zzso in the therapy of cancer pain management, starting with a newly developed 5 zzso tablet every 12 zzso 

Twenty-two Japanese cancer patients with pain who had not been taking zzso analgesics over the previous 2 weeks were zzso The length of time and the dose needed to attain stable and adequate pain control were evaluated in addition to the assessment of zzso efficacy and safety during the study zzso 

zzso patients in the efficacy population (18 out of 20, zzso attained stable, adequate pain zzso zzso of the patients attained stable, adequate pain control without any dose zzso The mean length of time was zzso zzso In these patients, the pain was significantly reduced in intensity, even at 1 h after the initial dose zzso Fifteen patients zzso reported at least one side effect, but only one patient had to withdraw from the study because of a side zzso 

The results suggest that zzso zzso zzso offered stable and adequate pain control within a short period of time in most Japanese cancer patients who have not been taking zzso zzso and could be effectively zzso against pain from a starting dose of 5 zzso every 12 zzso This indicates that a lower strength zzso zzso zzso may make it possible to start and zzso the dose more appropriately and carefully in patients who are sensitive to zzso zzso 

